Pain in Guillain–Barré syndrome

References

• van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome. Lancet Neurol.7, 939–950 (2008).
   PubMed Web of Science ®Google Scholar
• Guillain G, Barré JA, Strohl A. [Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916]. Ann. Med. Interne (Paris)150, 24–32 (1999).
   PubMedGoogle Scholar
• Ropper AH, Shahani BT. Pain in Guillain–Barré syndrome. Arch. Neurol.41, 511–514 (1984).
   PubMed Web of Science ®Google Scholar
• Andersson T, Siden A. A clinical study of the Guillain–Barré Syndrome. Acta Neurol. Scand.66, 316–327 (1982).
   PubMed Web of Science ®Google Scholar
• Forsberg A, Press R, Einarsson U, de Pedro-Cuesta J, Widen Holmqvist L. Impairment in Guillain–Barré syndrome during the first 2 years after onset: a prospective study. J. Neurol. Sci.227, 131–138 (2004).
   PubMed Web of Science ®Google Scholar
• Gorson KC, Ropper AH, Muriello MA, Blair R. Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain–Barré syndrome. Neurology47, 813–817 (1996).
   PubMed Web of Science ®Google Scholar
• Greenwood RJ, Newsom-Davis JM, Hughes RAC et al. Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lanceti, 877–879 (1984).
   Google Scholar
• Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain–Barré syndrome: a prospective multicentre study. Neuropediatrics38, 10–17 (2007).
   PubMed Web of Science ®Google Scholar
• Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain–Barré syndrome. Neurology48, 328–331 (1997).
   PubMed Web of Science ®Google Scholar
• Ruts L, van Koningsveld R, Jacobs BC, van Doorn PA. Determination of pain and response to methylprednisolone in Guillain–Barré syndrome. J. Neurol.254, 1318–1322 (2007).
   PubMed Web of Science ®Google Scholar
• Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. I: clinical features and their prognostic value. J. Neurol. Neurosurg. Psychiatry51, 605–612 (1988).
   PubMed Web of Science ®Google Scholar
• Green DM, Ropper AH. Mild Guillain–Barré syndrome. Arch. Neurol.58, 1098–1101 (2001).
   PubMedGoogle Scholar
• Koga M, Yuki N, Hirata K. Pain in Miller Fisher syndrome. J. Neurol.247, 720–721 (2000).
   PubMed Web of Science ®Google Scholar
• Ruts L, Rico R, van Koningsveld R et al. Pain accompanies pure motor Guillain–Barré syndrome. J. Peripher. Nerv. Syst.13, 305–306 (2008).
   PubMed Web of Science ®Google Scholar
• Bernsen RA, Jager AE, Schmitz PI, van der Meché FGA. Long-term sensory deficit after Guillain–Barré syndrome. J. Neurol.248, 483–486 (2001).
   PubMed Web of Science ®Google Scholar
• Ruts L, Drenthen J, Jongen JL et al. Pain in Guillain–Barré syndrome: a long-term follow-up study. Neurology75, 1439–1447 (2010).
   PubMed Web of Science ®Google Scholar
• Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann. Neurol.27(Suppl.), S21–S24 (1990).
   PubMed Web of Science ®Google Scholar
• Ropper AH. The Guillain–Barré syndrome. N. Engl. J. Med.326, 1130–1136 (1992).
   PubMed Web of Science ®Google Scholar
• Hadden RD, Cornblath DR, Hughes RAC et al. Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann. Neurol.44, 780–788 (1998).
   PubMed Web of Science ®Google Scholar
• Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain1, 277–299 (1975).
   PubMed Web of Science ®Google Scholar
• van der Kloot WA, Oostendorp RA, van der Meij J, van den Heuvel J. [The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire]. Ned. Tijdschr. Geneeskd.139, 669–673 (1995).
   PubMedGoogle Scholar
• McMahon KM. Wall and Melzack’s Texbook of Pain. Elsevier Health Sciences, London, UK (2009).
   Google Scholar
• Kleyweg RP, van der Meché FGA, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve14, 1103–1109 (1991).
   PubMed Web of Science ®Google Scholar
• Merkies IS, Schmitz PI, van der Meché FGA, van Doorn PA, Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Neurology54, 943–949 (2000).
   PubMed Web of Science ®Google Scholar
• Merkies IS, Schmitz PI, van der Meché FGA, van Doorn PA. Comparison between impairment and disability scales in immune-mediated polyneuropathies. Muscle Nerve28, 93–100 (2003).
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancetii, 750–753 (1978).
   Web of Science ®Google Scholar
• Sharrack B, Hughes RAC. The Guy’s Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult. Scler.5, 223–233 (1999).
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol.46, 1121–1123 (1989).
   PubMed Web of Science ®Google Scholar
• Ang CW, Jacobs BC, Brandenburg AH et al. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barré syndrome. Neurology54, 1453–1458 (2000).
   PubMed Web of Science ®Google Scholar
• Kuijf ML, van Doorn PA, Tio-Gillen AP et al. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA. J. Neurol. Sci.239, 37–44 (2005).
   PubMed Web of Science ®Google Scholar
• Jacobs BC, van Doorn PA, Schmitz PI et al.Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome. Ann. Neurol.40, 181–187 (1996).
   PubMed Web of Science ®Google Scholar
• Luongo L, Sajic M, Grist J et al. Spinal changes associated with mechanical hypersensitivity in a model of Guillain–Barré syndrome. Neurosci. Lett.437, 98–102 (2008).
   PubMed Web of Science ®Google Scholar
• Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy. Brain Behav. Immun.21, 699–710 (2007).
   PubMed Web of Science ®Google Scholar
• Pan CL, Tseng TJ, Lin YH et al. Cutaneous innervation in Guillain–Barré syndrome: pathology and clinical correlations. Brain126, 386–397 (2003).
   PubMed Web of Science ®Google Scholar
• Martinez V, Fletcher D, Martin F et al. Small fibre impairment predicts neuropathic pain in Guillain–Barré syndrome. Pain151, 53–60 (2010).
   PubMed Web of Science ®Google Scholar
• Monteiro JP, Fonseca S, Proenca J et al. Pediatric Guillain–Barré syndrome: experience in the neuropediatrics unit of a Portuguese hospital. Rev. Neurol.42, 144–149 (2006).
   PubMed Web of Science ®Google Scholar
• Rekand T, Gramstad A, Vedeler CA. Fatigue, pain and muscle weakness are frequent after Guillain–Barré syndrome and poliomyelitis. J. Neurol.256, 349–354 (2009).
   PubMed Web of Science ®Google Scholar
• van Koningsveld R, Steyerberg EW, Hughes RAC et al. A clinical prognostic scoring system for Guillain–Barré syndrome. Lancet Neurol.6, 589–594 (2007).
   PubMed Web of Science ®Google Scholar
• Li J, Bai Y, Ghandour K et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain128, 1168–1177 (2005).
   PubMed Web of Science ®Google Scholar
• Katona I, Wu X, Feely SM et al. PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain132, 1734–1740 (2009).
   PubMed Web of Science ®Google Scholar
• Stalder AK, Erne B, Reimann R et al. Immunoglobulin M deposition in cutaneous nerves of anti-myelin-associated glycoprotein polyneuropathy patients correlates with axonal degeneration. J. Neuropathol. Exp. Neurol.68, 148–158 (2009).
   PubMed Web of Science ®Google Scholar
• Umapathi T, Tan WL, Loke SC et al. Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve35, 591–598 (2007).
   PubMed Web of Science ®Google Scholar
• Polydefkis M, Hauer P, Sheth S et al. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain127, 1606–1615 (2004).
   PubMed Web of Science ®Google Scholar